Platform Enhancement & Validation
Broad (CNS, Oncology, Inflammation, etc.)
Key Facts
About SynVivo
SynVivo is a private company, founded in 2009 and headquartered in Huntsville, Alabama, that has established itself as a leader in the organ-on-a-chip (OoC) sector. It commercializes a portfolio of validated, ready-to-use microfluidic platforms (e.g., SynBBB, SynTumor, SynRAM) that mimic vascularized human tissue for predictive preclinical testing. Its business model combines product sales (chips, instruments, accessories) with fee-for-service offerings in screening and assay development, positioning it as a critical tools and services provider enabling the pharmaceutical industry's shift towards New Approach Methodologies (NAMs). The company is in a revenue-generating stage, serving academic, biotech, and pharma researchers.
View full company profile